相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy
Sunanda Pejavar et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts
David W. Ellison et al.
JOURNAL OF NEGATIVE RESULTS IN BIOMEDICINE (2011)
Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors
Marjut Puputti et al.
BRAIN PATHOLOGY (2010)
Recent Insights into PDGF-Induced Gliomagenesis
Filippo Calzolari et al.
BRAIN PATHOLOGY (2010)
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours
Ester Fonsatti et al.
CARDIOVASCULAR RESEARCH (2010)
Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis
Stergios Zacharoulis et al.
CHILDS NERVOUS SYSTEM (2010)
Tumor vessel biology in pediatric intracranial ependymoma Clinical article
Michiel Wagemakers et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2010)
Intracranial ependymoma: factors affecting outcome
Maura Massimino et al.
FUTURE ONCOLOGY (2009)
Ependymoma: An Update
Stergios Zacharoulis et al.
JOURNAL OF CHILD NEUROLOGY (2009)
Molecular origins of cancer: Tumor angiogenesis
Robert S. Kerbel
NEW ENGLAND JOURNAL OF MEDICINE (2008)
CD105 expression is an independent predictor of survival in patients with endometrial cancer
Ozlem Erdem et al.
GYNECOLOGIC ONCOLOGY (2006)
High expression of CD105 as a prognostic predictor of early tongue cancer
Hui-Ching Chuang et al.
LARYNGOSCOPE (2006)
Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma
Panayiotis A. Kyzas et al.
VIRCHOWS ARCHIV (2006)
ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors
JN Rich et al.
CLINICAL CANCER RESEARCH (2005)
Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival
M Preusser et al.
ACTA NEUROPATHOLOGICA (2005)
Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma:: Final results of the first prospective AIEOP (Associazione Italiana Di Ematologiaoncologia Pediatrica) study
M Massimino et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Recurrent spinal ependymoma showing partial remission under Imatimib
N Fakhrai et al.
ACTA NEUROCHIRURGICA (2004)
Endoglin (CD105) expression in endometrial carcinoma
RS Saad et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2003)
Endoglin (CD105): A target for anti-angiogenetic cancer therapy
E Fonsatti et al.
CURRENT DRUG TARGETS (2003)
CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas - Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients
JP Dales et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
分享论文
